Breast cancer drug cuts death risk
10th Dec 2005, 14:59 GMT
A new breast cancer drug that shuts off the supply of oestrogen has the potential to save thousands of lives in the UK, researchers said. Data from three international trials showed that switching from standard therapy to Arimidex after two years can reduce death rates by 29 per cent
Breast cancer drug cuts death risk related news:
- Drug for cancer is successful — Scotsman.com News - Breast cancer
- HERCEPTIN 'CUTS RISK' OF CANCER — Mirror.co.uk - News - Top Stories
- Breast cancer drug halves return risk — the Mail online | Health
- Breast cancer drug 'halves risk' — the Mail online | Health news
- Low-Fat Diet May Prevent Breast Cancer Recurrence — Breast Cancer Chronicles
- Herceptin proving to be a wonder drug — The Cardio Blog
- Breast cancer survivors face more risks — HEALTH
- Breast cancer increases risk of a second cancer — Health News
- New breast cancer drug prevents future cancer growth — The Cancer Blog
- Women With Breast Cancer Face Increased Risk Of Developing A Second Cancer — ScienceDaily Headlines: Health & Medicine
Latest news from the Mail online | Health:
- Designer twins are born healthy after screened for cystic fibrosis
- NICE refuse to fund life-prolonging cancer drug available in Scotland
- Dentist shortage leads man to superglue own tooth
- NICE refuses to fund life-prolonging cancer drug available in Scotland
- I was frozen to improve my health
- Why do I have dark circles under my eyes?
- Why smokers must have equal rights to health care
- Warning: Nurses at work
- I thought only women got osteoporosis - until my back exploded on the dance floor
- How you can snuff out the snuffles